Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga
Endocrinol Nutr. 2015 Dec;62(10):512-4.
doi: 10.1016/j.endonu.2015.07.004.
Epub 2015 Sep 28.
[Article in
English,
Spanish]
Affiliations
- 1 UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España; UGC de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, España. Electronic address: maroca80@gmail.com.
- 2 UGC de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, España.
- 3 UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España.
- 4 UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España; UGC de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, España.
No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Anthropometry
-
Blood Glucose / analysis
-
Blood Pressure / drug effects
-
Body Weight / drug effects
-
Cholesterol / blood
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Female
-
Glycated Hemoglobin / analysis
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use*
-
Lipids / blood
-
Male
-
Metabolic Syndrome / blood
-
Metabolic Syndrome / drug therapy
-
Middle Aged
-
Obesity / complications*
-
Peptides / pharmacology
-
Peptides / therapeutic use*
-
Prospective Studies
-
Spain
Substances
-
Blood Glucose
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
Lipids
-
Peptides
-
lixisenatide
-
Cholesterol